ENTRY       K13757                      KO
NAME        PDE6C
DEFINITION  cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' [EC:3.1.4.35]
PATHWAY     ko00230  Purine metabolism
DISEASE     H00481  Cone-rod dystrophy and cone dystrophy
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Metabolism
              Nucleotide metabolism
               00230 Purine metabolism
                K13757  PDE6C; cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'
            Enzymes [BR:ko01000]
             3. Hydrolases
              3.1  Acting on ester bonds
               3.1.4  Phosphoric-diester hydrolases
                3.1.4.35  3',5'-cyclic-GMP phosphodiesterase
                 K13757  PDE6C; cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'
DBLINKS     RN: R01234
            GO: 0047555
GENES       HSA: 5146(PDE6C)
            PTR: 740456(PDE6C)
            PPS: 100991111(PDE6C)
            GGO: 101147391(PDE6C)
            PON: 100444869(PDE6C)
            MCC: 700261(PDE6C)
            MCF: 102137434(PDE6C)
            MMU: 110855(Pde6c)
            RNO: 361752(Pde6c)
            CGE: 100752813(Pde6c)
            HGL: 101702814(Pde6c)
            TUP: 102496806(PDE6C)
            CFA: 486805(PDE6C)
            AML: 100480480(PDE6C)
            FCA: 101094627(PDE6C)
            PTG: 102948622(PDE6C)
            BTA: 281975(PDE6C)
            BOM: 102268034(PDE6C)
            PHD: 102326844(PDE6C)
            CHX: 102178237(PDE6C)
            SSC: 100512867(PDE6C)
            CFR: 102523928(PDE6C)
            BACU: 102997447(PDE6C)
            LVE: 103078830(PDE6C)
            ECB: 100061774(PDE6C)
            MYB: 102239901(PDE6C)
            MYD: 102756526(PDE6C)
            PALE: 102893557(PDE6C)
            MDO: 100023714(PDE6C)
            SHR: 100917797(PDE6C)
            OAA: 100088736
            GGA: 395834(PDE6C)
            TGU: 100231485(PDE6C)
            FAB: 101810613(PDE6C)
            PHI: 102105421(PDE6C)
            APLA: 101794535(PDE6C)
            FPG: 101917170(PDE6C)
            FCH: 102052630(PDE6C)
            CLV: 102092176(PDE6C)
            ASN: 102376891(PDE6C)
            AMJ: 102566982(PDE6C)
            PSS: 102456429(PDE6C)
            CMY: 102943469(PDE6C)
            ACS: 100566240
            PBI: 103060301(PDE6C)
            XTR: 100485634(pde6c)
            DRE: 393845(pde6c)
            TRU: 101062462 101066408
            MZE: 101478917
            OLA: 101163363
            XMA: 102224579
            LCM: 102366762(PDE6C)
            CMK: 103182613(pde6c)
REFERENCE   PMID:17307970
  AUTHORS   Omori K, Kotera J
  TITLE     Overview of PDEs and their regulation.
  JOURNAL   Circ Res 100:309-27 (2007)
REFERENCE   PMID:16102838
  AUTHORS   Lugnier C
  TITLE     Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
  JOURNAL   Pharmacol Ther 109:366-98 (2006)
///
